Patients taking bone medication often fear implants are off the table. The nuance most never hear: osteoporosis itself is rarely the obstacle. The medication class and its history are what change the plan. Seoul Top Dental Hospital in Seocho explains the conversation that matters.

Why bone drugs concern oral surgeons
Bisphosphonates and denosumab slow bone turnover, which protects hips and spines but also slows the jaw remodeling that surgery relies on. The feared complication is MRONJ, medication-related jaw necrosis: rare in osteoporosis dosing, measured in fractions of a percent, but real enough that planning respects it. Risk rises with years on the drug, intravenous forms, steroids alongside and major surgery rather than single implants.
What planning actually looks like
Bring the exact drug name, dose and start date; the plan follows those three facts. Short oral-dose histories commonly proceed with standard care plus closer follow-up. Longer histories bring physician coordination, sometimes blood markers of bone turnover, and honest discussion of timing. Drug holidays are debated territory decided with your prescribing doctor, never by the dental clinic alone. Osteoporosis without medication mostly means softer-bone protocols: adjusted drilling, longer healing before loading.

Signals to respect after surgery
Gum that stays open past expected healing, exposed bone, persistent dull jaw ache: uncommon, but each deserves a same-week call rather than patience. Routine maintenance visits double as early-warning checks for medicated patients.
Seoul Top Dental Hospital coordinates with prescribing physicians and plans bone-drug cases with written timelines, supporting international patients through the process. The medication list you almost forgot to mention is the most important document in this consultation.